In this special issue, known experts worldwide in related field are getting together to share their knowledge in terms of diagnosis and treatment of HCC. Apart from the up-to-date review in HCC, You will also be able to learn the status of HCC in a wide geographic background including Asia, Europe and America. We hope you will enjoy this special issue.
The outline for this special issue is as follows:
Preface
Ghassan K. Abou-Alfa
Memorial Sloan-Kettering Cancer Center, New York, USA
Hepatitis Risk Factors
Maya Gambarin
Section of Gastroenterology, Memorial Sloan-Kettering Cancer Center, New York, USA
Scoring and staging
Alan Venook
Professor of Clinical Medicine, Division of Hematology Oncology, University of California San Francisco, San Francisco, CA, USA
Cirrhosis management
Roniel Cabrera
Department of Medicine, Section of Hepatobiliary Diseases, University of Florida, FL, USA
Surgical and Transplant interventions
IoannisKonstantinidis andYuman Fong
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA
Local Therapies
Jeffrey Geschwind
Director of Vascular and Interventional Radiology, Interventional Radiology Center, Johns Hopkins Hospital, Baltimore, MD, USA
Systemic therapy for HCC
James Harding and Ghassan K. Abou-Alfa
Section of Gastrointestinal Cancer, Memorial Sloan-Kettering Cancer Center, New York, USA
Status of HCC in China
Shuki Qin
Chair of Chinese Society of Clinical Oncology (CSCO); Deputy director of People’s Liberation Army (PLA) 81 Hospital (Nanjing, China); Director of Cancer Center of Chinese PLA
Status of HCC in Japan
Masafumi Ikeda
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Status of HCC in Korea
HooGuen Chun
Comprehensive Cancer Institute, Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Korea
Status of HCC in Egypt
Ashraf Abdelaziz
Section of Gastroeneterology, Cairo University, Egypt
Status of HCC in India
G. S. Bhattacharyya
Dept. of Medical Oncology, FORTIS Hospitals, Anandapur, EM Byepass, Kolkata, India, AMRI,Kolkata, India
Status of HCC in USA
Andrew Zhu
Liver Cancer Research，Massachusetts General Hospital Cancer Center, Boston, MA, USA
Status of HCC in Europe
Tim Meyer
UCL Cancer Institute, University College London, London, United Kingdom